Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 8,868,000 | 8,146,000 | 7,925,000 | 8,545,000 | 8,518,000 |
| Cost of Goods | 2,864,000 | 2,608,000 | 2,516,000 | 2,902,000 | 2,874,000 |
| Gross Profit | 6,004,000 | 5,538,000 | 5,409,000 | 5,643,000 | 5,644,000 |
| Operating Expenses | 3,977,000 | 4,013,000 | 3,919,000 | 3,825,000 | 3,860,000 |
| Operating Income | 2,027,000 | 1,525,000 | 1,490,000 | 1,818,000 | 1,784,000 |
| Interest Expense | 154,000 | 145,000 | 147,000 | 154,000 | 147,000 |
| Other Income | -228,000 | -228,000 | 44,000 | -439,000 | -143,000 |
| Pre-tax Income | 1,645,000 | 1,152,000 | 1,387,000 | 1,225,000 | 1,494,000 |
| Income Tax | 381,000 | 350,000 | 274,000 | 132,000 | 275,000 |
| Net Income Continuous | 1,221,000 | 804,000 | 1,118,000 | 1,095,000 | 1,248,000 |
| Minority Interests | -31,000 | -27,000 | -34,000 | -39,000 | -35,000 |
| Net Income | $1,190,000 | $777,000 | $1,084,000 | $1,056,000 | $1,213,000 |
| EPS Basic Total Ops | 0.91 | 0.59 | 0.82 | 0.80 | 0.92 |
| EPS Basic Continuous Ops | 0.91 | 0.59 | 0.82 | 0.80 | 0.92 |
| EPS Diluted Total Ops | 0.91 | 0.59 | 0.82 | 0.80 | 0.92 |
| EPS Diluted Continuous Ops | 0.91 | 0.59 | 0.82 | 0.80 | 0.92 |
| EBITDA(a) | $2,360,000 | $1,921,000 | $2,211,000 | $2,061,000 | $2,330,000 |